Blackhawk Capital Partners Llc. Abb Vie Inc. Transaction History

Blackhawk Capital Partners Llc.

$158 Million
Q1 2024

A detailed history of Blackhawk Capital Partners Llc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Blackhawk Capital Partners Llc. holds 11,274 shares of ABBV stock, worth $2.09 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

11,274

Previous 11,334 0.53%

Holding current value

$2.09 Million

Previous $1.76 Million 16.86%

% of portfolio

1.3%

Previous 1.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $9,589 - $10,926	-60 Reduced 0.53%	11,274 $2.05 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $16,485 - $18,985	-114 Reduced 1.0%	11,334 $1.81 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $300,824 - $360,767	-2,175 Reduced 15.97%	11,448 $1.85 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $1.27 Million - $1.61 Million	9,223 Added 209.61%	13,623 $2.09 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $2.39 Million - $2.97 Million	-18,109 Reduced 80.45%	4,400 $713,000

Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $49,740 - $62,935	463 Added 2.1%	22,509 $3.05 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $302,069 - $342,894	2,839 Added 14.78%	22,046 $2.38 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $49,133 - $54,737	467 Added 2.49%	19,207 $2.08 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $2,966 - $3,265	-29 Reduced 0.15%	18,740 $2.01 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $82,985 - $112,038	1,031 Added 5.81%	18,769 $1.64 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $628,689 - $737,873	-7,318 Reduced 29.21%	17,738 $1.74 Million
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $127,590 - $170,735	-1,739 Reduced 6.49%	25,056 $1.91 Million
Q1 2020 Apr 03, 2020	SELL	$64.5 - $97.79 $180,858 - $274,203	-2,804 Reduced 9.47%	26,795 $2.37 Million
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $207,519 - $249,497	3,295 Added 12.53%	29,599 $2.24 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $364,897 - $466,424	5,554 Added 26.77%	26,304 $1.91 Million
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $680,606 - $801,040	8,823 Added 73.98%	20,750 $1.67 Million
Q4 2018 Feb 04, 2019	BUY	$77.85 - $96.01 $640,627 - $790,066	8,229 Added 222.53%	11,927 $1.1 Million
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $13,377 - $15,828	149 Added 4.2%	3,698 $343,000
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $32,847 - $43,985	-357 Reduced 9.14%	3,549 $336,000
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $349,821 - $383,608	3,906	3,906 $378,000

Others Institutions Holding ABBV

# of Institutions

3,647

Shares Held

1.23B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $327B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

News

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.

Account

Blackhawk Capital Partners Llc. Abb Vie Inc. Transaction History